论文部分内容阅读
FDA批准了一种新型糖蛋白缀合体作为乙型脑膜炎疫苗进入临床实验。本文简要介绍了这种疫苗的研制过程、免疫学特征和作用机制等。作为首例乙型脑膜炎疫苗的该糖蛋白缀合体获得成功 ,对于研究其他疫苗将具有重要的指导意义。
FDA approved a new glycoprotein conjugate to enter clinical trials as a meningitis B vaccine. This article briefly describes the development of this vaccine, immunological characteristics and mechanisms of action. The success of this glycoprotein conjugate as the first meningitis B vaccine will be of great guiding significance for the study of other vaccines.